Triferic Avnu

Active Ingredient(s): Ferric Pyrophosphate Citrate
FDA Approved: * March 27, 2020
Category: Anemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Triferic Avnu Overview

In chemistry, pyrophosphates are phosphorus oxyanions that contain two phosphorus atoms in a P-O-P linkage. A number of pyrophosphate salts exist, such as disodium pyrophosphate (Na2H2P2O7) and tetrasodium pyrophosphate (Na4P2O7), among others. Often pyrophosphates are called diphosphates. The parent pyrophosphates are derived from partial or complete neutralization of pyrophosphoric acid. The pyrophosphate bond is also sometimes referred to as a phosphoanhydride bond, a naming convention w...

Read more Triferic Avnu Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Triferic Avnu Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ferric Pyrophosphate Citrate
  • For Solution: 272mg Iron/packet
  • Solution: 27.2mg Iron/5ml (5.44mg Iron/ml), 27.2mg/5ml, 272mg Iron/50ml (5.44mg Iron/ml), 272mg/50ml, 5.44mg Fe/ml, 6.75mg Iron/4.5ml (1.5mg Iron/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Triferic Avnu: (1 result)

Sorted by National Drug Code
  • 57278-318 Triferic Avnu 1.5 mg/ml Intravenous Solution by Rockwell Medical Inc.

Other drugs which contain Ferric Pyrophosphate Citrate or a similar ingredient: (2 results)